Vitamins as influenza vaccine adjuvant components

Area of Science:

• Immunology
• Vaccinology
• Biotechnology

Background:

• Adjuvants are crucial for enhancing vaccine immunogenicity.
• Optimizing adjuvant formulations can improve vaccine efficacy against influenza.

Purpose of the Study:

• To assess the immunogenicity and memory response of various adjuvant formulations combined with an H1N1 influenza vaccine in mice.
• To identify promising adjuvant combinations for human vaccine development.

Main Methods:

• Mice were immunized with an H1N1 vaccine and different adjuvant combinations, including vitamins, emulsions, Bordetella pertussis (MPLA), alum, and squalene.
• Immune responses were measured using hemagglutination inhibition (HAI) tests, ELISA for IgG subclasses, and cytokine quantification (IFN-γ, IL-2, IL-6, IL-10).
• Immunological memory was evaluated via a booster dose and subsequent antibody analysis.

Main Results:

• Adjuvant combinations with vitamin E, or MPLA/alum, and B2/alum demonstrated the highest increases in HAI and IgG titers.
• The B2/alum combination suggested a stronger Th2 immune response compared to MPLA/alum.
• MPLA/alum and B2/alum formulations induced significant HAI titer increases after a booster dose, indicating robust immunological memory.

Conclusions:

• MPLA with alum and B2 with alum emerged as the most effective adjuvant combinations among the 27 tested.
• These promising adjuvants warrant further evaluation in human clinical trials for influenza vaccines.